Array
(
[id] => 3452509
[patent_doc_number] => 05451499
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-09-19
[patent_title] => 'Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/055530
[patent_app_country] => US
[patent_app_date] => 1993-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11015
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/451/05451499.pdf
[firstpage_image] =>[orig_patent_app_number] => 055530
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/055530 | Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof | Apr 29, 1993 | Issued |
Array
(
[id] => 4050481
[patent_doc_number] => 05869624
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/037816
[patent_app_country] => US
[patent_app_date] => 1993-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 34
[patent_no_of_words] => 15443
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869624.pdf
[firstpage_image] =>[orig_patent_app_number] => 037816
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/037816 | HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof | Mar 25, 1993 | Issued |
Array
(
[id] => 3618022
[patent_doc_number] => 05593698
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-14
[patent_title] => 'Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides'
[patent_app_type] => 1
[patent_app_number] => 8/027127
[patent_app_country] => US
[patent_app_date] => 1993-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 5392
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/593/05593698.pdf
[firstpage_image] =>[orig_patent_app_number] => 027127
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/027127 | Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides | Mar 4, 1993 | Issued |